학술논문

First-results of the CLIMB360 study, a prospective molecular screening program across multiple cancer types based on circulating tumor DNA (ctDNA)
Document Type
Journal
Source
ANNALS OF ONCOLOGY; 2021, 32 pS396-pS397, 2p. Supplement: 5
Subject
Language
English
ISSN
15698041